Intangible Assets

NSPR does not appear to possess durable brand, patent, or regulatory-intangible advantages that translate into peer-leading pricing power or retention, so its position is weaker than established medtech peers with broader IP portfolios and clinical franchises.

The provided TTM ROIC of -1.53% indicates the company is not converting its asset base into economic returns, which is inconsistent with an intangible-led moat that would support premium margins versus peers.

No evidence in the supplied data indicates proprietary clinical data, physician loyalty, or reimbursement protection strong enough to create durable differentiation, unlike larger device peers that can defend share through entrenched product ecosystems.

With no 5-year profitability or margin history provided and negative current returns, any intangible advantage appears limited and not yet durable enough to materially improve 5–10 year pricing power.

Switching Costs

NSPR does not show evidence of high switching costs because the available metrics do not indicate sticky installed-base economics, recurring consumables dependence, or workflow integration that would lock in customers versus peers.

A cash conversion cycle of 124.1 days suggests working-capital intensity rather than customer lock-in, which is the opposite of the retention profile typically seen in businesses with strong switching costs.

Compared with peers that benefit from procedure standardization, training effects, or platform integration, NSPR appears more exposed to competitive substitution and purchasing decisions based on price and clinical preference.

Negative ROIC further suggests customers are not being monetized through a durable installed base, limiting the likelihood that switching costs are protecting margins over time.

Network Effects

There is no evidence that NSPR benefits from network effects, because the supplied data do not show user growth loops, platform participation, or ecosystem-driven adoption that would make the product more valuable as usage expands.

Unlike peer platforms where more users, data, or providers reinforce adoption, NSPR appears to sell a product rather than operate a self-reinforcing network, so peer dependence is minimal.

The negative ROIC and low asset turnover do not support a scaling flywheel that would typically accompany network effects and improve retention or pricing power.

In peer terms, NSPR looks structurally isolated rather than ecosystem-centered, which leaves competitive advantage dependent on product performance rather than network reinforcement.

Cost Advantage

NSPR shows no clear cost advantage because the provided TTM ROIC is negative and asset turnover of 0.24x indicates weak capital productivity relative to what a cost leader would typically exhibit.

A business with a durable cost advantage should usually convert scale into superior unit economics, but the available metrics instead point to inefficient asset use and limited operating leverage.

Compared with stronger peers that can spread fixed manufacturing, regulatory, or commercial costs across larger volumes, NSPR does not appear to have a structurally lower cost base.

The absence of margin history in the supplied data prevents proof of sustained cost leadership, and the current return profile argues against one.

Efficient Scale

NSPR does not appear to operate in a clearly protected niche where market size is small enough to support efficient scale and deter entry, because the supplied data do not show monopoly-like share or regulated scarcity.

The negative ROIC suggests the company is not extracting excess returns from a limited market structure, which is inconsistent with efficient-scale economics versus peers.

Unlike peers in highly concentrated subsegments that can sustain pricing discipline through limited demand, NSPR appears exposed to normal competitive pressure without evidence of structural capacity constraints.

The available metrics do not indicate that industry economics are naturally capping competition in NSPR’s favor, so efficient scale is not a meaningful moat driver.

Overall Score

NSPR’s moat appears weak versus peers because the available evidence shows negative capital returns, low asset productivity, and no demonstrated structural advantage in intangibles, switching costs, network effects, cost position, or efficient scale.